Skip to search formSkip to main contentSkip to account menu

pafencil

Known as: 4-di(2-chloroethyl)aminophenacetyl-4-aminobenzoic acid, paphencil, paphencyl 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
1991
1991
Clinical and laboratory indications of hemocoagulatory disorders (according to the data of electrocoagulograph H-334 and red… 
1991
1991
Three different programs of polychemotherapy (PCT) of multiple myeloma (MM) were compared. The programs included the use of… 
1985
1985
Pafencyl, a new antineoplastic drug, approved for use in the USSR, was administered orally to Wistar rats bearing subcutaneous… 
1985
1985
Pafencyl, a new antineoplastic drug, approved for use in the USSR, was administered orally to Wistar rats bearing subcutaneous… 
1982
1982
It has been found that paphencyl, preparations II-72 and II-119 decrease to an equal measure the leukocyte count in the… 
1981
1981
Experiments on CBA mice immunized with sheep red blood cells have shown that paphencyl, promycil, prospidin and imidazole-4… 
1981
1981
The paper deals with a comparison of the results of treatment of 19 patients with malignant lymphomas, mostly diffuse ones, stage…